180 related articles for article (PubMed ID: 8225873)
1. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
Samples JR; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3386-95. PubMed ID: 8225873
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
Alexander JP; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
[TBL] [Abstract][Full Text] [Related]
3. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.
Bradley JM; Vranka J; Colvis CM; Conger DM; Alexander JP; Fisk AS; Samples JR; Acott TS
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2649-58. PubMed ID: 9856774
[TBL] [Abstract][Full Text] [Related]
4. Effects of mechanical stretching on trabecular matrix metalloproteinases.
Bradley JM; Kelley MJ; Zhu X; Anderssohn AM; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1505-13. PubMed ID: 11381054
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
6. Effects of interleukin-1beta and dexamethasone on the expression of matrix metalloprotease mRNA by trabecular cells exposed to elevated hydrostatic pressure.
Ehrich D; Tripathi B; Tripathi R; Duncker G
Acta Ophthalmol Scand; 2005 Feb; 83(1):104-8. PubMed ID: 15715567
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
[TBL] [Abstract][Full Text] [Related]
8. A major role for matrix metalloproteinases in T cell injury in the gut.
Pender SL; Tickle SP; Docherty AJ; Howie D; Wathen NC; MacDonald TT
J Immunol; 1997 Feb; 158(4):1582-90. PubMed ID: 9029093
[TBL] [Abstract][Full Text] [Related]
9. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression.
Alexander JP; Samples JR; Acott TS
Curr Eye Res; 1998 Mar; 17(3):276-85. PubMed ID: 9543636
[TBL] [Abstract][Full Text] [Related]
10. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1beta and TNFalpha.
Bradley JM; Anderssohn AM; Colvis CM; Parshley DE; Zhu XH; Ruddat MS; Samples JR; Acott TS
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):422-30. PubMed ID: 10670472
[TBL] [Abstract][Full Text] [Related]
11. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells.
Parshley DE; Bradley JM; Fisk A; Hadaegh A; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):795-804. PubMed ID: 8603864
[TBL] [Abstract][Full Text] [Related]
12. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork.
Parshley DE; Bradley JM; Samples JR; Van Buskirk EM; Acott TS
Curr Eye Res; 1995 Jul; 14(7):537-44. PubMed ID: 7587299
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork.
Wirtz MK; Xu H; Rust K; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):45-53. PubMed ID: 9430544
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
Girard MT; Matsubara M; Fini ME
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
[TBL] [Abstract][Full Text] [Related]
15. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
16. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
Li L; Akers K; Eisen AZ; Seltzer JL
Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
[TBL] [Abstract][Full Text] [Related]
17. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants.
Snyder RW; Stamer WD; Kramer TR; Seftor RE
Exp Eye Res; 1993 Oct; 57(4):461-8. PubMed ID: 8282032
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages.
Sarén P; Welgus HG; Kovanen PT
J Immunol; 1996 Nov; 157(9):4159-65. PubMed ID: 8892653
[TBL] [Abstract][Full Text] [Related]
20. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
